Integrating Clinical Operations And Pharmacovigilance for Safer Trials

Clinical operations and pharmacovigilance often move forward on separate tracks, creating blind spots that can slow trials and complicate safety decisions. In early-phase and complex studies — where risk profiles are still evolving—those gaps can translate into protocol amendments, inconsistent safety oversight, and added burden on sites and study teams.

This on-demand discussion explores how earlier, intentional integration across clinical operations, medical monitoring, and pharmacovigilance can improve oversight from the start. Experts share where silos most commonly emerge, how disconnected planning drives downstream issues, and what a more connected approach looks like in practice—from protocol strategy and trial conduct to case processing, signal detection, and risk management. Attendees will come away with practical guidance for strengthening benefit–risk decision-making, reducing operational friction, and protecting development timelines while keeping patient safety at the center.

Watch on demand to learn how integrated planning can help complex studies stay on track.